Dyadic Announces Collaboration with Jiangsu Hengrui Medicine for Biologic Drug Development

LIANYUNGANG, CHINA and JUPITER, FL / ACCESSWIRE / August 17, 2020 / Dyadic International, Inc. (“Dyadic” or the “Company”) (NASDAQ:DYAI), a global biotechnology company focused on further applying its proprietary C1 gene expression platform to accelerate development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales, today announced collaboration […]

Dyadic Announces Collaboration with Jiangsu Hengrui Medicine for Biologic Drug Development

LIANYUNGANG, CHINA and JUPITER, FL / ACCESSWIRE / August 17, 2020 / Dyadic International, Inc. (“Dyadic” or the “Company”) (NASDAQ:DYAI), a global biotechnology company focused on further applying its proprietary C1 gene expression platform to accelerate development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales, today announced collaboration […]